CHE Chemed Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CHE

Price (delayed)

$548.17

Market cap

$8.74B

P/E Ratio

32.25

Dividend/share

$1.32

EPS

$17

Enterprise value

$8.76B

Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.chemed.com/

Highlights

The debt is down by 46% year-on-year and by 6% since the previous quarter
Chemed's quick ratio has increased by 42% from the previous quarter and by 39% YoY
The price to earnings (P/E) is 10% higher than the last 4 quarters average of 29.4 and 9% higher than the 5-year quarterly average of 29.6

Key stats

What are the main financial stats of CHE
Market
Shares outstanding
15.95M
Market cap
$8.74B
Enterprise value
$8.76B
Valuations
Price to earnings (P/E)
32.25
Price to book (P/B)
10.89
Price to sales (P/S)
4.22
EV/EBIT
26.33
EV/EBITDA
22.52
EV/Sales
4.24
Earnings
Revenue
$2.07B
EBIT
$332.88M
EBITDA
$389.21M
Free cash flow
$410.08M
Per share
EPS
$17
Free cash flow per share
$25.73
Book value per share
$50.34
Revenue per share
$129.78
TBVPS
$41.91
Balance sheet
Total assets
$1.37B
Total liabilities
$565.55M
Debt
$132.55M
Equity
$801.41M
Working capital
-$58.57M
Liquidity
Debt to equity
0.17
Current ratio
0.82
Quick ratio
0.68
Net debt/EBITDA
0.05
Margins
EBITDA margin
18.8%
Gross margin
32.8%
Net margin
13.1%
Operating margin
15.7%
Efficiency
Return on assets
20.9%
Return on equity
36.6%
Return on invested capital
72.1%
Return on capital employed
32.1%
Return on sales
16.1%
Dividend
Dividend yield
0.24%
DPS
$1.32
Payout ratio
7.8%

CHE stock price

How has the Chemed stock price performed over time
Intraday
0.54%
1 week
3.58%
1 month
3.04%
1 year
14.13%
YTD
2.92%
QTD
2.92%

Financial performance

How have Chemed's revenue and profit performed over time
Revenue
$2.07B
Gross profit
$678.12M
Operating income
$323.88M
Net income
$271.29M
Gross margin
32.8%
Net margin
13.1%
Chemed's operating income has increased by 31% YoY and by 3% from the previous quarter
The net income has grown by 30% year-on-year and by 3.3% since the previous quarter
The operating margin has increased by 19% YoY
The net margin is up by 18% year-on-year

Growth

What is Chemed's growth rate over time

Valuation

What is Chemed stock price valuation
P/E
32.25
P/B
10.89
P/S
4.22
EV/EBIT
26.33
EV/EBITDA
22.52
EV/Sales
4.24
The EPS has increased by 30% YoY and by 3.4% from the previous quarter
The price to earnings (P/E) is 10% higher than the last 4 quarters average of 29.4 and 9% higher than the 5-year quarterly average of 29.6
The P/B is 40% more than the 5-year quarterly average of 7.8 and 12% more than the last 4 quarters average of 9.7
Chemed's equity has increased by 19% YoY and by 7% from the previous quarter
CHE's P/S is 62% above its 5-year quarterly average of 2.6 and 17% above its last 4 quarters average of 3.6
The revenue rose by 10% year-on-year and by 2.4% since the previous quarter

Efficiency

How efficient is Chemed business performance
The company's return on invested capital rose by 26% YoY and by 13% QoQ
The ROS has increased by 21% YoY
The ROA rose by 9% year-on-year
The ROE has grown by 8% YoY

Dividends

What is CHE's dividend history
DPS
$1.32
Dividend yield
0.24%
Payout ratio
7.8%
Recent dividends

Financial health

How did Chemed financials performed over time
Chemed's total assets is 142% higher than its total liabilities
Chemed's quick ratio has increased by 42% from the previous quarter and by 39% YoY
CHE's current ratio is up by 39% from the previous quarter and by 22% YoY
The debt is 83% smaller than the equity
CHE's debt to equity has dropped by 54% year-on-year and by 11% since the previous quarter
The debt is down by 46% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.